![Jean-Paul Renaud](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jean-Paul Renaud active positions
Companies | Position | Start | End |
---|---|---|---|
Urania Therapeutics SAS
![]() Urania Therapeutics SAS BiotechnologyHealth Technology Urania Therapeutics SAS develops therapeutic solutions for the treatment of genetic diseases caused by pathogenic nonsense mutations. The company was founded by Jean-Paul Renaud, Marat Yusupova, and Gulnara Yusupova in October 2015 and is headquartered in Illkirc, France. | Director/Board Member | 30/09/2015 | - |
Chief Tech/Sci/R&D Officer | 30/09/2015 | - | |
Founder | 30/09/2015 | - | |
President | 30/09/2015 | - |
Career history of Jean-Paul Renaud
Former positions of Jean-Paul Renaud
Companies | Position | Start | End |
---|---|---|---|
NovAliX SAS
![]() NovAliX SAS BiotechnologyHealth Technology NovAliX SAS operates as a drug discovery-focused contract research organization. It offers drug discovery services in the fields of chemistry, collaborative models, biophysics and biology. The company was founded by Stephan Jenn and Jean-Paul Renaud in 2002 and is headquartered in Illkirch, France. | Chief Tech/Sci/R&D Officer | 31/12/2001 | - |
Founder | 31/12/2001 | - |
Statistics
International
France | 3 |
Operational
Chief Tech/Sci/R&D Officer | 2 |
Founder | 2 |
Director/Board Member | 1 |
Sectoral
Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
NovAliX SAS
![]() NovAliX SAS BiotechnologyHealth Technology NovAliX SAS operates as a drug discovery-focused contract research organization. It offers drug discovery services in the fields of chemistry, collaborative models, biophysics and biology. The company was founded by Stephan Jenn and Jean-Paul Renaud in 2002 and is headquartered in Illkirch, France. | Health Technology |
Urania Therapeutics SAS
![]() Urania Therapeutics SAS BiotechnologyHealth Technology Urania Therapeutics SAS develops therapeutic solutions for the treatment of genetic diseases caused by pathogenic nonsense mutations. The company was founded by Jean-Paul Renaud, Marat Yusupova, and Gulnara Yusupova in October 2015 and is headquartered in Illkirc, France. | Health Technology |
- Stock Market
- Insiders
- Jean-Paul Renaud
- Experience